Skip to main content
. 2023 Apr 6;24(7):6856. doi: 10.3390/ijms24076856
ABPP Aβ binding peptide probe
AD Alzheimer’s disease
Ahx 6-aminohexanoic acid
Aβ42 amyloid-beta 42
BB2R bombesin receptor 2
BB3 bombesin receptor 3
BCa breast cancer
BMG-1 cerebral glioma cell line
CADD computer-aided drug design
CCK cholecystokinin receptors
CCK-2R cholecystokinin receptor subtype 2
CCP positively charged octamer
cDNA complementary DNA
CP04 minigastrin analog DOTA-(dGlu)-6-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2
CSF cerebral-cerebrospinal fluid
C-X-C chemokine receptors
CXCR4 chemokine receptor 4
DBCO dibenzocyclooctyne
DCIBzL ((1-carboxy-5-(4-iodobenzamido)pentyl)carbamoyl)glutamic acid
DOTA 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
DOTATOC 1,4,7,10-tetraazacyclododecan-4,7,10-tricarboxy-meth-1-yl-acetyl-d-Phe-Tyr3-octreotide
DTPA pentetic acid, diethylenetriaminepentaacetic acid
EAT Xenografted Ehrlich Ascites
ELISA enzyme-linked immunosorbent assay
ESCC esophageal squamous cell carcinoma
Fmoc fluorenylmethoxycarbonyl protecting group
GCP II glutamate carboxypeptidase II
GGT gamma glutamyl transferase
GRPR gastrin releasing peptide receptor
GSH glutathione
HBED-CC N,N′-bis-[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N-diacetic acid
HIV-1 human immunodeficiency virus
MD molecular dynamics
MMPs matrix metalloproteases
MOLCAD Computer-Aided Visualization and Manipulation of Models
MTC medullary thyroid carcinoma cells
NOTA 2,2′,2″-(1,4,7-triazacyclononane-1,4,7-triyl)triacetic acid
NOTA-CP01 cyclo[Phe-Tyr-Lys-(iPr)-d-Arg-2-Nal-Gly-d-Glu]-Lys-(iPr)-butane-1,4-diamine-bis-t-butyl NOTA-NH2
PCa prostate cancer
PEG polyethylene glycol
PET positron emission tomography
PSMA prostate-specific membrane antigen
RM2 gastrin-releasing peptide receptor antagonist
S1 non-prime section
S1′ prime section
SAAC single amino acid chelated
SAR structure–activity relationship
SDF-1/CXCL12 stromal cell-derived factor 1
Siglec-9 sialic acid-binding Ig-like lectin 9
SPECT single-photon emission computed tomography
SSTR2 somatostatin receptor subtype 2
TE1K1P−PEG4−DBCO−Y3-TATE
TRNT targeted radionuclide therapy
VAP-1 vascular adhesion protein-1
Y3-TATE tyrosine 3-octreotate